fbpx Skip to main content

Member's Profile

ACADIA Pharmaceuticals

12830 El Camino Real Ste 400
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 1997
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About ACADIA Pharmaceuticals
Biotech Company
ACADIA Pharmaceuticals (Nasdaq: ACAD) is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is focused on developing a portfolio consisting of its four most advanced product candidates directed at large unmet medical needs and major commercial markets. ACADIA’s pipeline includes pimavanserin in Phase III for Parkinson’s disease psychosis, a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and ACP-16 in IND-track development. All of the product candidates in ACADIA’s product pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA’s headquarters are located in San Diego, California, and it maintain research and development operations in both San Diego and Malmo, Sweden.
Related News
No related news posted by this Member